Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cannapharmarx Inc (CPMD)
OTHER OTC:CPMD
Cannapharmarx (CPMD) Stock Price & Analysis
56 Followers
CPMD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.00 - $0.03
Previous Close$0.01
Volume158.85K
Average Volume (3M)354.15K
Market Cap
$7.62M
Enterprise Value$15.17M
Total Cash (Recent Filing)$12.09K
Total Debt (Recent Filing)$7.56M
Price to Earnings (P/E)―
Beta-4655.36
Next Earnings
Aug 19, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding662,501,405
10 Day Avg. Volume206,937
30 Day Avg. Volume354,153
Standard Deviation763.35
R-Squared0.00729
Alpha113.87
Financial Highlights & Ratios
Price to Book (P/B)-0.18
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)8.50
P/FCF Ratio2.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue587.16
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-3.22
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Cannapharmarx News
PremiumCompany Announcements
CannaPharmaRx Achieves First Harvest Milestone
PremiumCompany Announcements
CannaPharmaRx Targets High Growth in 2023
PremiumCompany Announcements
CannaPharmaRx Expands to Latin America with ICAN
PremiumCompany Announcements
CannaPharmaRx Schedules Investor Update CallPremiumCompany Announcements
CannaPharmaRx Gains Key Certifications for Global Growth
PremiumCompany Announcements
CannaPharmaRx Welcomes Dean Medwid as CEOPremiumCompany Announcements
CannapharmaRx Launches Global Cannabis DistributionPremiumCompany Announcements
CannaPharmaRx Targets Global Cannabis LeadershipOwnership Overview
4.48%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
95.52% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CPMD FAQ
What was Cannapharmarx Inc’s price range in the past 12 months?
Cannapharmarx Inc lowest stock price was $0.00 and its highest was $0.03 in the past 12 months.
What is Cannapharmarx Inc’s market cap?
Currently, no data Available
When is Cannapharmarx Inc’s upcoming earnings report date?
Cannapharmarx Inc’s upcoming earnings report date is Aug 19, 2024 which is in 25 days.
How were Cannapharmarx Inc’s earnings last quarter?
Cannapharmarx Inc released its earnings results on May 21, 2024. The company reported -$0.033 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.033.
Is Cannapharmarx Inc overvalued?
According to Wall Street analysts Cannapharmarx Inc’s price is currently Overvalued.
Does Cannapharmarx Inc pay dividends?
Cannapharmarx Inc does not currently pay dividends.
What is Cannapharmarx Inc’s EPS estimate?
Cannapharmarx Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cannapharmarx Inc have?
Cannapharmarx Inc has 662,501,400 shares outstanding.
What happened to Cannapharmarx Inc’s price movement after its last earnings report?
Cannapharmarx Inc reported an EPS of -$0.033 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cannapharmarx Inc?
Currently, no hedge funds are holding shares in CPMD
---
Cannapharmarx Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
―
20 days / 200 days
Momentum
-21.42%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
115.63%
Trailing 12-Months
Company Description
Cannapharmarx Inc
CannaPharmaRx, Inc. engages in the research and manufacture of cannabinoid-based pharmaceuticals. It focuses on the treatment of disease states such as neurological disorders, oncology, infectious disease, pain management, inflammatory disease, gastrointestinal disorders, and ophthalmology. The company was founded in August 1998 and is headquartered in Kelowna, Canada.
---
Technical Analysis
---